发明名称 |
Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
摘要 |
An NSAID formulation for encapsulation into a soft gel capsule with increased stability, concentration and bioavailability of the NSAID. The preferred NSAIDS are naproxen, ibprofen, indomethacin and diclofenac, which are provided in both an acidic and basic form in the fill formulation. The pH values of fill formulations may be adjusted without additional process steps. A process for increasing the achievable concentration of an NASAID pharmaceutical ingredient in a fill composition for dosage units is also provided. The highly concentrated NASAID formulation permits a reduction in the fill volume or dosage unit size or an increase in concentration of the NSAID in each dosage it. |
申请公布号 |
US9480667(B2) |
申请公布日期 |
2016.11.01 |
申请号 |
US201113574159 |
申请日期 |
2011.01.19 |
申请人 |
ACCUCAPS INDUSTRIES LIMITED |
发明人 |
Lopez John;Draper Peter;Vashishtha Sankalp;Klassen Nancy;Armstrong Christina |
分类号 |
A61K31/192;A61K31/4402;A61K31/405;A61K9/48;A61K45/06 |
主分类号 |
A61K31/192 |
代理机构 |
McBee, Moore, Woodward, Vanik IP, LLC |
代理人 |
McBee, Moore, Woodward, Vanik IP, LLC |
主权项 |
1. A pharmaceutical fill formulation of a non-steroidal anti-inflammatory drug (NSAID) suitable for encapsulation in a soft gel, consisting of:
a) 2%-25% of naproxen; b) 25%-2% of naproxen sodium; c) 40%-70% polyethylene glycol; d) 1%-5% propylene glycol; e) 1%-6% povidone; f) 1%-10% water, and g) 0%-4% of an additional active pharmaceutical ingredient, wherein the total amount of naproxen and naproxen sodium ranges from about 22% to about 30% by weight of the total composition. |
地址 |
Windsor CA |